Beyond The Breast

Image result for I'm sorry for not being fully consideratee

I admit … I love the fact that one post, blog, thought can lead to others! Not so much to post or blog but it refreshes the mind to go passed the former thought in the previous moment. Flushing out our ideas is always a good idea. My significant other once questioned the approach. He said, “But is there a such thing as thinking too much?” We can, oftentimes, go to “far” with it, but to me {also in response to him} how can you broaden the mindset if you’re unwilling to go passed the first thought? The reason why we can write is because the mind is constantly flushing through craving that, maybe, there is more we don’t see and/or understand.

Doesn’t this remind you of God? How in the world did He come up with the plan of the earth let alone everything else. We are floating in what we know as a universe on an axis with the capability to remain in the same spot. The earth is literally turning so we can have changes in seasons, time, weather, etc. It is the coolest thing ever!

Image result for I'm sorry for not being fully consideratee

To this point is yesterday’s post. I addressed the frequency of working hard to reshape my body and searched some natural ways to shrink the breast. That forced me to think — but what about those who lose their breast due to breast cancer?! I’m so sorry for my selfishness! This can cause you to feel less than. Instead of my “frustrated complaint” maybe I should be thankful that I have what I have; just keep working out in hopes that the desired shape will happen!

There are new studies for cancer! Cancer is not a death sentence!! It shouldn’t be a word that scares us or anyone connected to us! Knowing, as is known, is half the battle! So, I submit to you some new findings ….

What is the new treatment for cancer? The FDA has approved a form of gene therapy called CAR T-cell therapy. It uses some of your own immune cells, called T cells, to treat your cancer. Doctors take the cells out of your blood and change them by adding new genes so they can better find and kill cancer cells. Nov 11, 2018 New Ideas in Cancer Treatment – WebMD › cancer › cancer-new-research-treatment

Cancer Treatment Research – National Cancer Institute › about-cancer › treatment › research

A team of researchers has developed a potential new therapy that may work in two distinct ways to attack tumors, by directly killing cancer cells and immune cells that can suppress the anti-cancer immune response. Drug resistance is a common occurrence that can lead to tumor relapse and patient death.


Cancer. A word that fills people with dread. A powerful, devastating word that has destroyed so many lives of cancer victims, their families and loved ones. A word that scientists and doctors are actively and fervently working towards making just a memory.

Every year there are new breakthroughs in oncology research and cancer treatments. Unfortunately a lot of these experimental treatments take years to develop and to run them through the required clinical trials, and they still don’t always pan out in the end. This top ten list, however, is going to walk you through some of the most exciting experimental cancer treatments currently being tested or administered in pre-clinical trials. Scientists are the most hopeful about these experimental cancer treatments right now and explain why they might be viable options for cancer patients. Some of these treatments are still in the early stages of development, whereas others are currently in pre-clinical and clinical trials to test how viable they are as treatments.


Radiation therapies are any number of therapies that utilize different forms of radiation to try and cause cancerous tumors to go into remission.


Image result for there is hope

Hyperthermia Therapy is an experimental form of cancer therapy that utilizes localized or whole-body administration of heat. Intense heating will cause denaturation and coagulation of cellular proteins, rapidly killing the cells within a tumor. What this means is the protein cells will lose their quaternary structure, tertiary structure and secondary structure which causes cell disruption and cell death. A mild heat-treatment in combination of other stresses can also cause apoptosis of the cell, which means the cell dies and creates fragments which are called apoptotic bodies, which can be cleaned up by phagocytic cells. Phagocytic cells engulf these apoptotic bodies which destroys them, rendering them unable to cause damage to surrounding cells.

Hyperthermia Therapy is very exciting because, if it turns out to be a viable treatment, this will destroy the cancerous tumors from the inside out and hinder its ability to infect more healthy cells. This therapy type is currently in the very early stages of development, as scientists need to dial in how much heat is needed to destroy these cells.

The application of heat to treat certain medical conditions, including possible tumors, has a very long history. Ancient Greeks, Romans, and Egyptians used heat to treat breast masses; this is still a recommended self-care treatment for breast engorgement. Medical practitioners in ancient India used regional and whole-body hyperthermia as treatments for various medical maladies as well. During the 19th century, tumor shrinkage after a high fever caused by infections was reported in a small number of cases. Because of this, properly conducted clinical trials were conducted in the early 1970’s using hyperthermia therapy in an attempt to reduce or kill cancerous growths in patients. The ancient usage of hyperthermia treatment, the reported cases of tumor-shrinkage in the early 19th century and the clinical trials performed in the 1970’s comprise the basis for today’s treatments utilizing hyperthermia therapy.

Fact: More than 30% of cancer could be prevented, mainly by not using tobacco, having a healthy diet, being physically active and moderating the use of alcohol. In developing countries up to 20% of cancer deaths could be prevented by immunization against the infection of HBV and HPV.


Non-invasive cancer treatments require no incisions in a patient’s skin or excisions of living tissue. These reduce the recovery time associated with cancer therapy, and would also suit patients whose overall health precludes surgical or otherwise invasive treatment. Many non-invasive treatments also reduce the risk of common cancer treatment side effects, such as brain fog and gastrointestinal upset, when compared to drugs or radiation therapies.

One treatment involves injecting metallic nanoparticles, including gold, carbon nanotubes, or zinc ferrite, into the tumor. Doctors would then heat these nanoparticles up using magnetic fields or radio waves, killing the surrounding cancer cells. The particles would need to heat up quickly to successfully kill the cancer cells, however, due to the tendency of the body to carry heat away from a given location. These treatments have not yet reached clinical trials, but show promise.

Tumor treating fields have been approved for treatment since 2011. These electric fields make it more difficult for aggressive cancers, such as glioblastoma multiforme, to continue dividing, which can both diminish growth and reduce the chance that the cancer will spread. These treatments give comparable results to additional rounds of chemotherapy in some patients, but unlike chemotherapy or radiation, tumor treating fields therapies have no associated pain, fatigue, nausea, or gastrointestinal distress, giving patients a better quality of life.

Image result for there is hope

High-Intensity Focused Ultrasound (HIFU) treatment uses focused sound waves to destroy cancerous cells in the bone, brain, breast, liver, pancreas, rectum, kidneys, testes, and prostate. While approved by the U.S. Food and Drug Administration, HIFU is still in its early stages, and the full potential of ultrasound in the fight against cancer has not yet been fully explored. In addition to being non-invasive, HIFU also introduces no radiation, has few side effects, and does not require a hospital stay.

Fact: There are more than 100 types of cancer; any part of the human anatomy can be affected by cancer.


A possible form of gene therapy is the introduction of enzymes into cancerous cells that make them susceptible to particular chemotherapy agents; introducing thymidine kinase in gliomas, which make them susceptible to Aciclovir is the current study being worked on into this form of experimental treatment. Thymidine kinase have a key function in the synthesis of DNA and, due to this function, it plays a key role in cell division as well, as they are part of the unique reaction chain to introduce thymidine into the DNA. Aciclovir (ACV) also known as Acyclovir is an antiviral medication primarily used in the treatment of herpes simplex virus infections, chickenpox and shingles. This treatment is thought to be highly effective, but it is still in its early developmental stages and, as such, it could take some time before it even reaches clinical trials. Scientists are hopeful that this form of treatment will prove to be effective however, which they base on the amount of research that has currently gone into it.

The basis of gene therapy is the introduction of tumor suppressor genes into rapidly dividing cells, which is thought by most scientist to slow down or arrest tumor growth. Adenoviruses are a commonly utilized vector for the purpose of hindering tumor growth. Adenoviruses represent the largest non-enveloped virus group currently known. Due to how Adenoviruses behave and their cell structure, they have long been a popular viral vector for gene therapy due to their ability to affect both replicating and non-replicating cells, accommodate large transgenes, and code for proteins without integrating into the host cell genome. More specifically, Adenoviruses are used as a vehicle to administer targeted therapy in form of recombinant DNA or proteins. This makes Adenoviruses one of the most viable vectors for gene therapy currently known.

Fact: In 2008, 7.6 million people died of cancer – 13% of all deaths worldwide.


Immunotherapy uses the body’s natural defense mechanisms to fight off cancerous cells. These treatments are often less toxic and often more effective than other forms of therapy.


Immunotherapeutic vaccines are a form of vaccine that gives your body the tools it needs to fight off cancer. Sipuleucel-T (Provenge) is currently the only FDA approved Immunotherapeutic vaccine in use. Sipuleucel-T is used for individuals with advanced prostate cancer that are no longer benefiting from or responding to other forms of cancer treatment such as hormone therapy. With this treatment immune system cells are removed from the patient’s blood and are sent to a lab. At the lab, the cells are exposed to chemicals that turn them into special immune cells called dendritic cells. The dendritic cells are then exposed to a protein called prostatic acid phosphatase (PAP), which should produce an immune response against prostate cancer cells. This form of treatment is currently available to the public with great results. Currently a form of this treatment is in works for various other forms of cancer such as lung and bladder cancers, but these treatments are currently in the early development stages; scientists are hopeful that when the experimental treatments are put into clinical trials they will have the same success rate for eradicating other forms of cancer as it currently has had with eradicating prostate cancer.

One form of immunotherapy is to use Monoclonal antibodies to treat cancer. Normal antibodies are specific proteins that stick to other proteins called antigens. Once antibodies attach to an antigen, they signal other antibodies to attach to it as well, and they all attack it to destroy it. Monoclonal antibodies (mAbs) are antibodies designed by researchers to attack specific antigens, such as the ones found in cancer. Once designed, researchers produce a large number of these Monoclonal antibodies in a lab and introduce them into a patient’s body to fight off cancerous cells. For this to work, researchers first have to identify the right antigen to attack. For cancer, this is not always easy, and so far mAbs have proven to be more useful against some cancers than others. This is still being investigated by researchers to work against a wider range of cancers.

Fact: Cancers of major public health relevance such as breast, cervical and colorectal cancer can be cured if detected early and treated adequately.


Adoptive cell transfers involves removing immune system cells (usually white blood cells) from a patient’s body, re-engineering them to teach them how to fight against specific forms of cancerous cells and then re-infusing them back into the patient’s body. These experimental cancer treatments have to be specifically tailored to each patient, making them resource-intensive and thus not as easily scalable as other forms of cancer treatment. Adoptive cell transfers are used for various other treatments, as it’s the main way to improve a cell’s functionality, particularly its ability to fight off illnesses. Trials of this therapy began in the 1990’s but really accelerated in 2010. There have been numerous examples of highly promising results with tumor-specific, adoptive cellular immunotherapy in early clinical trials, but such treatments are not yet widely available at this time. Scientists are currently working on how to make this a more accessible treatment option for patients.

The theory behind adoptive cell transfer therapy was discovered in the 1960s, when lymphocytes were found to mediate allograft rejection in animals. Doctors successfully transferred lymphocytes between rodents to inhibit tumor growth. This has opened new avenues in cancer treatment.

Adoptive cell therapy uses T cells, a type of immune cell that naturally occurs within the human body, to fight cancer and other diseases. Doctors take T cells from the patient’s blood or tumor tissue, then grow them in much larger numbers than the body would manage on its own before reintroducing them to the patient’s body. Sometimes, this process also includes modifications to the T cells that will make them more capable of destroying cancer tissues.

Image result for there is hope

A similar process using T cells from a donor, rather than the patient’s own T cells, has been researched, but not all results have been positive. Finding appropriate donors can be difficult or even impossible for some otherwise promising avenues of treatment.

Fact: About 70% of all cancer deaths occur in low- and middle-income countries.


Treatments that fall under the drug therapies category involve using man-made or natural drugs to promote cancer recovery.


Dichloroacetate (DCA) has been found in lab studies to reduce tumors in vivo in lab rats, and has a plausible scientific mechanism behind it: DCA appears to reactivate suppressed mitochondria in some types of oxygen-starved tumor cells, and thus promotes apoptosis. Apoptosis, as stated earlier, is a perfect way to rid the body of cancerous cells due to the way the body disposes of what is left over after apoptosis. Because this drug was tested for various other applications, we now know it is a relatively safe, available and inexpensive drug. This drug can also be taken orally, which is very convenient for a lot of patients. This drug, however, has only gone through a pre-clinical trial that consisted of five patients. Doctors have stated that four out of the five were probably extended due to the drug, but until it goes to full clinical trials we won’t know the extent of its cancer-fighting properties.

DCA is an acid, an analogue of acetic acid, in which 2 of the 3 hydrogen atoms of the methyl group have been replaced by chlorine atoms. Like the other chloroacetic acids, it has various practical applications because it inhibits what’s known as pyruvate dehydrogenase kinase which is a kinase enzyme. Pyruvate dehydrogenase kinase (PDK) has been shown to have increased activity in hypoxic cancer cells, which are cancer cells that have a decreased oxygen flow. Because DCA inhibits PDK, it shows potential as a viable treatment for hypoxic cancer cells in patients. Pre-clinical trials have shown that it inhibits cancerous growths in vitro in animals. DCA can only be administered in a carefully controlled laboratory setting, however, as improper usage or dosage can easily cause liver damage or other complications, so taking DCA without a doctor’s orders or not following a doctor’s orders exactly is something that is strongly discouraged for general cancer patients.

Fact: One-fifth of all cancers worldwide are caused by a chronic infection, for example human papillomavirus (HPV) causes cervical cancer and hepatitis B virus (HBV) causes liver cancer.


Quercetin is a dietary supplement that makes for an excellent free-radical-scavenging antioxidant and it also promotes apoptosis in cancerous cells. In vitro it has been proven to have anti-tumor proclivities in both oral cancer and leukemia. Cultured skin and prostate cancer cells showed significant mortality (compared to nonmalignant cells) when treated with a combination of quercetin and ultrasound. Interestingly enough, ultrasound promotes topical absorption of up to 1,000% making a topical Quercetin and ultrasound combination to be a possible option for experimental cancer treatment. Quercetin is found in most fruits, vegetables, leaves and grains, which is why a diet high in these items can be very advantageous for many cancer patients. When taken orally, such as eating products that naturally contain it, it can be a helpful supplement to other cancer treatments, but doctors are trying to find a way to create a topical ointment that will work against cancerous cells to use in combination with ultrasound therapy. The topical ointment is still in early development, but the food items that contain this antioxidant are readily available on the market.

Some foods containing Quercetin are as follows: capers (canned or fresh), black plums, cranberries, fennel, radish leaves, dill, cilantro, red onions, kale, sweet potato, blueberries, Red Delicious apples, broccoli and black or green teas. A diet high in these foods as a supplement can sometimes help inhibit cancerous growths. This should by no means be used as a cancer treatment replacement, only as a supplement. Quercetin has the capability to inhibit cancerous cells from multiplying, but it isn’t as effective on its own as other treatments. Popular treatment options involving Quercetin are usually radiation therapy or Adoptive Cell Transfer Therapies that utilize a diet rich in Quercetin as a complimenting supplement.

Fact: Tobacco use is the single largest preventable cause of cancer in the world causing 22% of cancer deaths.


Image result for there is hope

Doctors at Memorial Sloan Kettering Cancer Center offered a 49-year old patient with melanoma growths an experimental combination of two drugs: Opdivo and Yervoy, both of which are manufactured by Bristol-Myers Squibb. Both of these drugs are new medications that boost the immune system so it can attack cancerous growths. Three weeks after the first dose, the patient’s melanoma growths had disappeared completely. Afterwards, doctors launched a 142-patient study on the effects of Opdivo and Yervoy when taken in combination. An astounding 22% of the study group had what’s known as a complete response to the drugs; that is to say that their cancerous growths completely disappeared. This drug combination, however, boosts a high toxicity rate along with it’s high success rate, so scientists are currently looking into ways to combat the toxicity they cause in patients. These drugs are still currently in the clinical trial phase, but should be readily available to advanced case patients in the near future; cases where the toxicity chance is more preferable to letting the unresponsive cancer continue to spread.

Opdivo is what is known as a programmed death receptor which blocks antibodies and is used for the treatment of unresectable or metastatic melanoma and metastatic squamous non-small-cell lung carcinoma. In contrast to traditional chemotherapies and targeted anti-cancer therapies, which exert their effects by direct cytotoxic or tumor growth inhibition, nivolumab acts by inducing the immune system to attack the tumor.

Yervoy is a monoclonal antibody (mAbs) that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system. It was approved by the U.S. FDA in 2011 for the treatment of melanoma, a type of skin cancer and is currently undergoing clinical trials for use in treating non-small cell lung carcinoma, small cell lung cancer, bladder cancer and metastatic hormone-refractory prostate cancer.

Fact: About 70% of all cancer deaths occur in low- and middle-income countries.



Early clinical trials using Clostridium novyi-NT spores to consume the interior of some tumors have shown promising results. The bacteria eat through the interior of oxygen-poor tumors, then die as they reach the oxygenated sides of the tumor. This reduces the number of cancerous cells, and in turn makes treatment easier. The bacteria cannot consume oxygenated parts of the tumor on their own, so this type of treatment requires follow-up with another treatment method to remove oxygenated cancer cells. This reduction in tumor size can help avoid cancer-related issues such as infections and hypoxia.

This treatment relies on the inherent differences between a patient’s healthy cells and those within the tumor, and the bacteria’s ability to live in only one of those environments. C. novyi cannot live in oxygenated environments like the human body, but can safely live, consume, and multiply within hypoxic environments like the center of a tumor. As a result, they cannot directly harm the patient, but will eat through most of the mass of a tumor. In some patients, the presence of the bacteria also encourages tumor-specific immune responses, further helping the body to fight the cancer.

Early trials did display some potential issues with the treatment as well, however. Two patients chosen for the most aggressive C. novyi treatment, which injected more than three million spores into the tumor, underwent sepsis and gas gangrene. Safe dosage has currently been set at one million spores. This treatment can also cause increased inflammation in the surrounding tissue, which makes it difficult for scientists to perfectly reflect tumor reduction within the experimental data.

Other strains of anaerobic bacteria have been considered for similar treatment methods. One promising solution involves injecting a non-toxic prodrug along with bacteria that can process it into a tumor-killing drug. This would enable doctors to introduce the tumor-killing drug exclusively in hypoxic areas of the tumor, keeping the rest of the patient’s body safe.

Fact: Worldwide, the 5 most common types of cancer that kill women are (in the order of frequency): breast, lung, stomach, colorectal and cervical. In many developing countries, cervical cancer is the most common cancer.


This therapy which utilizes genetically-modified Poliovirus samples is an extremely new treatment option for cancer patients. Researchers at The Preston Robert Tisch Brain Tumor Center at Duke University modified the poliovirus with portion of a cold-causing rhinovirus which removed the intrinsic disease-causing properties of the poliovirus. This genetically-modified virus has been dubbed the “PVS-RIPO” virus and it works by being directly infused into a patient’s tumor (such as a brain tumor). Once inside the tumor, PVS-RIPO then proceeds to infect and kill the cancerous cells. PVS-RIPO has remarkable cancer regression capabilities on its own, but it’s real power lies in the fact that it alerts your body’s natural defense mechanisms into fighting against the cancerous cells as well. The human immune system is trained to fight against viral infections and, as such, it recognizes the now infected cancer cells as being viral in nature and it attacks them. The body doesn’t normally attack cancer cells on its own due to the fact that cancer cells have a sort of “shield” around them that causes the immune system to not be able to “see” it properly.

The PVS-RIPO poliovirus was invented by Matthias Gromeier, MD, Associate Professor of Surgery, Associate Professor in Molecular Genetics and Microbiology, and Associate Professor of Medicine at Duke University School of Medicine, more than 2 decades ago, when he discovered that many cancer cells, including glioblastoma cells, produce the poliovirus receptor Necl-5/CD155. Glioblastoma multiforme (GBM), also known as glioblastoma and grade IV astrocytoma, is the most common and aggressive form of cancer that begins within the brain. People that suffer from this form of cancer almost never recover, but with the help of PVS-RIPO, sufferers may now have a chance to fight against this type of cancer.

Fact: Worldwide, the 5 most common types of cancer that kill men are (in order of frequency): lung, stomach, liver, colorectal and esophagus.


Experimental cancer treatments are medical therapies designed to improve, supplement or replace traditional cancer treatments (surgery, chemotherapy and radiation) in an attempt to reduce or remove cancerous growths. As you can see, all of the listed treatments are very exciting in nature and, if they become viable, can hopefully help us eradicate cancer.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.